Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Amiloride Action Pathway (New)
Homo sapiens
Drug Action Pathway
Amiloride is a pyrizine compound used to treat hypertension and congestive heart failure.It is a pyrazine compound inhibiting sodium reabsorption through sodium channels in renal epithelial cells. This inhibition creates a negative potential in the luminal membranes of principal cells, located in the distal convoluted tubule and collecting duct. Negative potential reduces secretion of potassium and hydrogen ions. Amiloride is used in conjunction with diuretics to spare potassium loss. Amiloride works by inhibiting sodium reabsorption in the distal convoluted tubules and collecting ducts in the kidneys by binding to the amiloride-sensitive sodium channels, at the alpha, beta, gamma, and delta subunits. This promotes the loss of sodium and water from the body, but without depleting potassium. Amiloride exerts its potassium sparing effect through the inhibition of sodium reabsorption at the distal convoluted tubule, cortical collecting tubule and collecting duct; this decreases the net negative potential of the tubular lumen and reduces both potassium and hydrogen secretion and their subsequent excretion. Amiloride is not an aldosterone antagonist and its effects are seen even in the absence of aldosterone. It can be found under the brand name Midamor. Some side effects of using this drug may include high blood potassium levels, vomiting, rash, and headache.
References
Amiloride Pathway (New) References
Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M: DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. doi: 10.1093/nar/gkx1037.
Pubmed: 29126136
Brater DC: Pharmacology of diuretics. Am J Med Sci. 2000 Jan;319(1):38-50. doi: 10.1097/00000441-200001000-00004.
Pubmed: 10653443
Davies DL, Wilson GM: Diuretics: mechanism of action and clinical application. Drugs. 1975;9(3):178-226. doi: 10.2165/00003495-197509030-00003.
Pubmed: 1092541
Vidt DG: Mechanism of action, pharmacokinetics, adverse effects, and therapeutic uses of amiloride hydrochloride, a new potassium-sparing diuretic. Pharmacotherapy. 1981 Nov-Dec;1(3):179-87. doi: 10.1002/j.1875-9114.1981.tb02539.x.
Pubmed: 6927605
Marunaka, Y. (1970, January 01). [PDF] Characteristics and pharmacological regulation of epithelial Na+ channel (ENaC) and epithelial Na+ transport.: Semantic Scholar. Retrieved July 30, 2020, from https://www.semanticscholar.org/paper/Characteristics-and-pharmacological-regulation-of-Marunaka/97cb0aff5601d950ac72780612cb38459d803e78
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
Downloads
Settings